Market Cap: $1.45B
PI
Pacira BioSciences, Inc.
PCRX
NASDAQ (NASDAQ Global Select)USD
Market Cap: $1.45B
Pacira BioSciences (Ticker: PCRX) announces the successful election of its board nominees, marking a pivotal moment for its leadership amidst ongoing advancements in non-opioid pain therapies. The 202…
Pacira BioSciences, Inc. (Ticker: PCRX), a leading player in innovative non-opioid pain therapies, focuses on maximizing shareholder value through strategic governance and operational performance. Ahe…
### Governance Strain at Pacira BioSciences: A Call for Change Concerns regarding corporate governance at Pacira BioSciences arise as DOMA Perpetual Capital Management LLC, a significant shareholder,…
Reforming Governance at Pacira BioSciences: A Call for Change Pacira BioSciences faces critical pressure from DOMA Perpetual Capital Management LLC, which holds about 7.1% of the company's outstanding…
Investor Push for Governance Overhaul at Pacira BioSciences Amid Performance Woes DOMA Perpetual Capital Management LLC raises significant alarms regarding the operational and governance status of Pac…
Investor Activism Highlights Governance Issues at Pacira BioSciences DOMA Perpetual Capital Management LLC expresses strong concerns regarding the governance and operational performance of Pacira BioS…
Pacira BioSciences Shows Strong Growth Trajectory with EXPAREL Demand Pacira BioSciences, renowned for its innovative contributions to pain management, reports significant revenue growth in its Q4 ear…
Pacira BioSciences: Advances in Innovative Pain Management Solutions Pacira BioSciences is at the forefront of transforming pain management within the healthcare landscape. The company specializes in…
Pacira BioSciences: Innovating Pain Management Solutions in a Competitive Landscape Pacira BioSciences stands at the forefront of the healthcare sector, particularly in the field of non-opioid pain ma…
Pacira BioSciences: Pioneering Innovations in Post-Surgical Pain Management Pacira BioSciences is at the forefront of transforming post-surgical pain management through its innovative technology and p…
Pacira BioSciences: Navigating a Complex Biotech Landscape In recent weeks, analysts have been actively evaluating Pacira BioSciences, a prominent player in the biotechnology sector known for its inno…
Pacira BioSciences: Navigating the Complexities of the Biotech Landscape Pacira BioSciences is currently at a pivotal juncture as it seeks to leverage its product pipeline amid mixed sentiments from i…
Corporate Governance at Pacira BioSciences Faces Scrutiny Amid Shareholder Activism In recent developments, DOMA Perpetual Capital Management LLC, a significant stakeholder in Pacira BioSciences, Inc.…
Increasing Pressure on Pacira BioSciences for Governance Reforms Amid growing scrutiny over corporate governance, DOMA Perpetual Capital Management LLC, a significant shareholder in Pacira BioSciences…
Pacira BioSciences Faces Corporate Governance Challenge Amid Calls for Change Pacira BioSciences, a biopharmaceutical company specializing in non-opioid pain management solutions, is currently under s…
Urgent Call for Strategic Review at Pacira BioSciences In a significant move that underscores rising tensions between shareholders and management, DOMA Perpetual Capital Management LLC, a major stakeh…
Pacira BioSciences Faces Pressure for Strategic Overhaul Amid Shareholder Discontent Pacira BioSciences, Inc. finds itself in a critical situation as DOMA Perpetual Capital Management LLC, a significa…
Pacira BioSciences Remains Focused on Innovation Amid Industry Earnings Reports In the current landscape of the biopharmaceutical industry, Pacira BioSciences stands out for its commitment to developi…
Innovative Pain Management Solutions: Pacira BioSciences’ Role in Advancing Patient Care Pacira BioSciences is at the forefront of revolutionizing pain management with its innovative drug, Exparel, wh…
Pacira BioSciences: Advancing Pain Management Solutions Pacira BioSciences is at the forefront of innovation in pain management, particularly through its flagship product, EXPAREL. This non-opioid, li…
Pacira BioSciences Adapts to Evolving Market Trends in Pain Management Pacira BioSciences, a leader in non-opioid pain management solutions, continues to position itself strategically within the evolv…
Pacira BioSciences Advances Innovative Pain Management Solutions Amid Economic Uncertainties Pacira BioSciences continues to carve out a prominent role in the evolving landscape of postoperative pain…
Emerging Trends in Pain Management: Pacira BioSciences’ Role in Transformative Therapies Pacira BioSciences is at the forefront of innovation in the pain management sector, focusing on the development…
Pacira BioSciences: Pioneering Non-Opioid Pain Management Solutions Pacira BioSciences stands at the forefront of addressing the critical need for effective pain management solutions that do not rely…
Pacira BioSciences Gears Up for Key Earnings Report Amidst Growth in Non-Opioid Solutions Pacira BioSciences is poised to unveil its quarterly earnings report on August 5, 2025, a development that has…